Lilly posts best weight-loss data; Bayer plans $2.2B Ohio plant; Aviceda shuts down

· Health · United States · Germany

Eli Lilly reported its best-ever weight-loss data, while Bayer detailed a $2.2 billion manufacturing site in New Albany, Ohio, expected to create about 600 jobs. Separately, geographic atrophy biotech Aviceda Therapeutics is winding down after a Phase 2 failure.

Why it matters：The moves show capital concentrating on obesity and large-scale manufacturing while late-stage failures continue to cull smaller biotechs, shaping pipeline and capacity competition globally.

Key points

  • Endpoints Weekly rounded up prominent deals, including Sanofi and Regeneron re-upping with $1 billion upfront
  • Bayer's New Albany site is described as creating about 600 jobs
  • Aviceda had planned to take an eye drug into Phase 3 this year despite a mid-stage setback

Sources (original reporting)

More stories from this day